Drogas antiinflamatorias no esteroides y el riesgo para la falla anastomótica

1. Schlachta CM, Burpee SE, Fernandez C, Chan B, Mamazza J, Poulin EC. Optimizing Recovery After Laparoscopic Colon Surgery (ORAL-CS): effect of intravenous ketorolac on length of hospital stay. Surg Endosc. 2007;21(12):2212-2219.
2. Klein M, Andersen LPH, Harvald T, Rosenberg J, Gogenur I. Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery. Dig Surg. 2009;26(1):27-30.
3. Holte K, Andersen J, Jakobsen DH, Kehlet H. Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg. 2009;96(6):650-654.
4. Rushfeldt CF, Sveinbjørnsson B, Søreide K, Vonen B. Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery. Int J Colorectal Dis. 2011;26(12):1501-1509
5. Gorissen KJ, Benning D, Berghmans T, et al. Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery. Br J Surg. 2012;99(5):721-727.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
7. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043-1049.
8. Silver K, Desormaux A, Freeman LC, Lillich JD. Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs. Growth Factors. 2012;30(4):258-266.
9. Freeman LC, Narvaez DF, McCoy A, et al. Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution. Biochem Pharmacol. 2007;74(1):74-85.
10. Silver K, Leloup L, Freeman LC, Wells A, Lillich JD. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. Int J Biochem Cell Biol. 2010;42(12):2030-2036.
11. Simon L, Mills J. Drug therapy: non-steroidal antiinflammatory drugs (first of two parts). N Engl J Med. 1980;302(21):1179-1185.
12. Horan TD, Noujaim AA, McPherson TA. Effect of indomethacin on human neutrophil chemiluminescence and microbicidal activity. Immunopharmacology. 1983;6(2):97-106.
13. Abramson S, Edelson H, Kaplan H, Ludewig R, Weissmann G. Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drugs. Am J Med. 1984;77(4B):3-6.
14. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21(4):977-980.
15. Busti AJ, Hooper JS, Amaya CJ, Kazi S. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy. 2005;25(11):1566-1591.
16. Haws MJ, Kucan JO, Roth AC, Suchy H, Brown RE. The effects of chronic ketorolac tromethamine (toradol) on wound healing. Ann Plast Surg. 1996;37(2):147-151.
17. Dong YL, Fleming RY, Yan TZ, Herndon DN, Waymack JP. Effect of ibuprofen on the inflammatory response to surgical wounds. J Trauma. 1993;35(3):340-343.
18. Riley GP, Cox M, Harrall RL, Clements S, Hazleman BL. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg Br. 2001;26(3):224-228.
19. Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children: epidemiology and review. Allergy. 1980;35(2):149-154.